Tag: VNS

Neuromodulation offers hope for patients with long-COVID

With increasing focus being placed on the long-term impact COVID-19 can have, and the demand for effective treatments also growing concurrently, Marom Bikson (New...

Neuromodulation for post-stroke recovery advancing on several fronts

As a principal investigator for the pivotal VNS-REHAB study, which supported the first US Food and Drug Administration (FDA) premarket approval of a vagus...

Dolphin vagus nerve stimulation receives Health Canada approval as COVID-19 treatment

Center for Pain and Stress Research today announced that its Dolphin vagus nerve stimulation (VNS) device has received breakthrough approval from Health Canada—making it...

Feinstein Institutes scientists develop “first-of-its-kind” wireless neuromodulation device for research

Engineers and researchers in the Institute of Bioelectronic Medicine at the Feinstein Institutes for Medical Research have developed a novel, fully implantable, wireless bidirectional vagus nerve stimulation (VNS)...

MicroTransponder receives best new product award for Vivistim system

MicroTransponder today announced that its Vivistim paired vagus nerve stimulation (VNS) system has won the Neurotech Reports Gold Electrode Award for best new product. This announcement...
vivistim system

MicroTransponder gains FDA approval for first-of-its-kind VNS system to improve stroke...

MicroTransponder has announced US Food and Drug Administration (FDA) premarket approval of the Vivistim paired vagus nerve stimulation (VNS) system, which—according to a company...

New study shows significant positive impact of vagus nerve stimulation therapy...

Adding vagus nerve stimulation (VNS) therapy to treatment as usual has been demonstrated to improve outcomes in patients with treatment-resistant bipolar depression (TRBD). In...
LivaNova RECOVER design published

RECOVER trial design evaluating vagus nerve stimulation for treatment-resistant depression published

LivaNova announces a publication in Contemporary Clinical Trials, which details the design for a prospective, multicentre, randomised controlled blinded trial demonstrating the safety and...
Peter Staats COVID-19 nVNS

Non-invasive vagus nerve stimulation may provide clinical benefit to patients with...

An article accepted into the journal Neuromodulation has concluded that, based on two case reports, non-invasive vagus nerve stimulation (nVNS) might provide clinical benefits...

LivaNova’s VNS Therapy receives CE mark for expanded MRI labelling

LivaNova's latest VNS Therapy system has received CE mark for expanded MRI labelling. VNS Therapy is now the only implantable device indicated for epilepsy...